Abaxis, Inc. (NASDAQ:ABAX)

CAPS Rating: 4 out of 5

The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.

Recs

0
Player Avatar 5starman (< 20) Submitted: 12/27/2011 11:29:50 PM : Outperform Start Price: $27.97 ABAX Score: +11.72

Low debt, lots of cash, growing business. High p/e, but i would pay a premium for growth.

Featured Broker Partners


Advertisement